No interaction found

Oflofine 0.3% w/v Eye Drop may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Oflofine 0.3% w/v Eye Drop is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.To reduce the amount of Oflofine 0.3% w/v Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

It is not known whether Oflofine 0.3% w/v Eye Drop alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

There is limited information available on the use of Oflofine 0.3% w/v Eye Drop in patients with kidney disease. Please consult your doctor.

There is limited information available on the use of Oflofine 0.3% w/v Eye Drop in patients with liver disease. Please consult your doctor.